Jiangsu Hengrui | 600276

Stock Price
51.63
Daily Change
-2.47 -4.57%
Monthly
-8.72%
Yearly
6.70%
Q1 Forecast
50.56

Date Reference Time Actual Consensus Previous
2026-04-20 FY2026Q1 AM 0.45 0.23
2026-03-25 FY2025Q4 AM 0.29 0.45 0.23
2025-10-27 FY2025Q3 AM 0.20 0.42 0.18
2025-08-20 FY2025Q2 AM 0.40 0.12 0.32
2025-05-01 FY2025Q1 0.30 0.18 0.21



Peers Price Chg Day Year Date
Cspc Pharmaceutical 8.16 -0.33 -3.89% 65.85% Mar/26
Sino Biopharmaceutical 5.82 -0.11 -1.86% 59.45% Mar/26
Sh Fosun Pharma 25.29 -0.07 -0.28% 1.20% Mar/26
Zhangzhou Pientzehuang Pharmaceutical 152.15 -1.92 -1.25% -26.19% Mar/26
Kangmei Pharma 1.74 -0.03 -1.69% -19.07% Mar/26
Sh Pharmaceutical 16.44 -0.14 -0.84% -15.35% Mar/26
WuXi AppTec 94.73 0.71 0.76% 39.31% Mar/26

Indexes Price Day Year Date
SHANGHAI 3889 -42.75 -1.09% 15.27% Mar/26
SHANGHAI 50 2825 -34.86 -1.22% 4.97% Mar/26

Jiangsu Hengrui Me. traded at 51.63 this Thursday March 26th, decreasing 2.47 or 4.57 percent since the previous trading session. Looking back, over the last four weeks, Jiangsu Hengrui lost 8.72 percent. Over the last 12 months, its price rose by 6.70 percent. Looking ahead, we forecast Jiangsu Hengrui Me. to be priced at 50.56 by the end of this quarter and at 47.24 in one year, according to Trading Economics global macro models projections and analysts expectations.

Jiangsu Hengrui Pharmaceuticals Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical tablets, injections and raw materials. The Company's main products portfolio consists of antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents, antibiotics, specialty infusions and others. The Company distributes its products within domestic market and to overseas markets.